Cargando…
Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1
Ferroptosis is a newly identified form of regulated cell death (RCD) characterized by the iron-dependent lipid reactive oxygen species (ROS) accumulation, but its mechanism in gliomas remains elusive. Acyl–coenzyme A (CoA) synthetase long-chain family member 4 (Acsl4), a pivotal enzyme in the regula...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192632/ https://www.ncbi.nlm.nih.gov/pubmed/35697672 http://dx.doi.org/10.1038/s41419-022-04997-1 |
_version_ | 1784726284295733248 |
---|---|
author | Miao, Zong Tian, Wei Ye, Yangfan Gu, Wei Bao, Zhongyuan Xu, Lei Sun, Guangchi Li, Chong Tu, Yiming Chao, Honglu Lam, Sin Man Liu, Ning Ji, Jing |
author_facet | Miao, Zong Tian, Wei Ye, Yangfan Gu, Wei Bao, Zhongyuan Xu, Lei Sun, Guangchi Li, Chong Tu, Yiming Chao, Honglu Lam, Sin Man Liu, Ning Ji, Jing |
author_sort | Miao, Zong |
collection | PubMed |
description | Ferroptosis is a newly identified form of regulated cell death (RCD) characterized by the iron-dependent lipid reactive oxygen species (ROS) accumulation, but its mechanism in gliomas remains elusive. Acyl–coenzyme A (CoA) synthetase long-chain family member 4 (Acsl4), a pivotal enzyme in the regulation of lipid biosynthesis, benefits the initiation of ferroptosis, but its role in gliomas needs further clarification. Erastin, a classic inducer of ferroptosis, has recently been found to regulate lipid peroxidation by regulating Acsl4 other than glutathione peroxidase 4 (GPX4) in ferroptosis. In this study, we demonstrated that heat shock protein 90 (Hsp90) and dynamin-related protein 1 (Drp1) actively regulated and stabilized Acsl4 expression in erastin-induced ferroptosis in gliomas. Hsp90 overexpression and calcineurin (CN)–mediated Drp1 dephosphorylation at serine 637 (Ser637) promoted ferroptosis by altering mitochondrial morphology and increasing Acsl4-mediated lipid peroxidation. Importantly, promotion of the Hsp90–Acsl4 pathway augmented anticancer activity of erastin in vitro and in vivo. Our discovery reveals a novel and efficient approach to ferroptosis-mediated glioma therapy. [Image: see text] |
format | Online Article Text |
id | pubmed-9192632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-91926322022-06-15 Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1 Miao, Zong Tian, Wei Ye, Yangfan Gu, Wei Bao, Zhongyuan Xu, Lei Sun, Guangchi Li, Chong Tu, Yiming Chao, Honglu Lam, Sin Man Liu, Ning Ji, Jing Cell Death Dis Article Ferroptosis is a newly identified form of regulated cell death (RCD) characterized by the iron-dependent lipid reactive oxygen species (ROS) accumulation, but its mechanism in gliomas remains elusive. Acyl–coenzyme A (CoA) synthetase long-chain family member 4 (Acsl4), a pivotal enzyme in the regulation of lipid biosynthesis, benefits the initiation of ferroptosis, but its role in gliomas needs further clarification. Erastin, a classic inducer of ferroptosis, has recently been found to regulate lipid peroxidation by regulating Acsl4 other than glutathione peroxidase 4 (GPX4) in ferroptosis. In this study, we demonstrated that heat shock protein 90 (Hsp90) and dynamin-related protein 1 (Drp1) actively regulated and stabilized Acsl4 expression in erastin-induced ferroptosis in gliomas. Hsp90 overexpression and calcineurin (CN)–mediated Drp1 dephosphorylation at serine 637 (Ser637) promoted ferroptosis by altering mitochondrial morphology and increasing Acsl4-mediated lipid peroxidation. Importantly, promotion of the Hsp90–Acsl4 pathway augmented anticancer activity of erastin in vitro and in vivo. Our discovery reveals a novel and efficient approach to ferroptosis-mediated glioma therapy. [Image: see text] Nature Publishing Group UK 2022-06-13 /pmc/articles/PMC9192632/ /pubmed/35697672 http://dx.doi.org/10.1038/s41419-022-04997-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Miao, Zong Tian, Wei Ye, Yangfan Gu, Wei Bao, Zhongyuan Xu, Lei Sun, Guangchi Li, Chong Tu, Yiming Chao, Honglu Lam, Sin Man Liu, Ning Ji, Jing Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1 |
title | Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1 |
title_full | Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1 |
title_fullStr | Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1 |
title_full_unstemmed | Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1 |
title_short | Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1 |
title_sort | hsp90 induces acsl4-dependent glioma ferroptosis via dephosphorylating ser637 at drp1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192632/ https://www.ncbi.nlm.nih.gov/pubmed/35697672 http://dx.doi.org/10.1038/s41419-022-04997-1 |
work_keys_str_mv | AT miaozong hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT tianwei hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT yeyangfan hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT guwei hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT baozhongyuan hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT xulei hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT sunguangchi hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT lichong hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT tuyiming hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT chaohonglu hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT lamsinman hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT liuning hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 AT jijing hsp90inducesacsl4dependentgliomaferroptosisviadephosphorylatingser637atdrp1 |